Upstream transcription factor 1 (USF1) polymorphisms associate with Alzheimer's disease-related neuropathological lesions: Tampere autopsy study

Brain Pathology

Volumn 22, Issue 6, 2012, Pages 765-775

  Isotalo, Karita ^a   Kok, Eloise Helena ^a   Luoto, Teemu M ^b   Haikonen, Satu ^a   Haapasalo, Hannu ^b   Lehtimäki, Terho ^a   Karhunen, Pekka J ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Alzheimer's disease; neurofibrillary tangles; senile plaques; upstream transcription factor 1

Indexed keywords

APOLIPOPROTEIN E; UPSTREAM STIMULATORY FACTOR 1;

ADOLESCENT; ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; AUTOPSY; BRAIN DAMAGE; CHILD; CHOLESTEROL BLOOD LEVEL; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HAPLOTYPE; HUMAN; HUMAN TISSUE; INFANT; MALE; NEUROFIBRILLARY TANGLE; NEWBORN; PRESCHOOL CHILD; SCHOOL CHILD; SENILE PLAQUE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AUTOPSY; CHILD; CHILD, PRESCHOOL; FEMALE; GENE FREQUENCY; HAPLOTYPES; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; UPSTREAM STIMULATORY FACTORS; YOUNG ADULT;

EID: 84867581847     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2012.00586.x     Document Type: Article

References (48)

1. Candore G, Balistreri CR, Grimaldi MP, Vasto S, Listi F, Chiappelli M, et al, (2006) Age-related inflammatory diseases: role of genetics and gender in the pathophysiology of Alzheimer's disease. Ann N Y Acad Sci 1089: 472-486.
2. Collings A, Hoyssa S, Fan M, Kahonen M, Hutri-Kahonen N, Marniemi J, et al, (2008) Allelic variants of upstream transcription factor 1 associate with carotid artery intima-media thickness: the Cardiovascular Risk in Young Finns study. Circ J 72: 1158-1164.
3. Coon H, Xin Y, Hopkins PN, Cawthon RM, Hasstedt SJ, Hunt SC, (2005) Upstream stimulatory factor 1 associated with familial combined hyperlipidemia, LDL cholesterol, and triglycerides. Hum Genet 117: 444-451.
4. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, et al, (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923.
5. Corder EH, Ghebremedhin E, Taylor MG, Thal DR, Ohm TG, Braak H, (2004) The biphasic relationship between regional brain senile plaque and neurofibrillary tangle distributions: modification by age, sex, and APOE polymorphism. Ann N Y Acad Sci 1019: 24-28.
6. Corre S, Galibert MD, (2005) Upstream stimulating factors: highly versatile stress-responsive transcription factors. Pigment Cell Res 18: 337-348.
7. Corre S, Primot A, Baron Y, Le Seyec J, Goding C, Galibert M, (2009) Target gene specificity of USF-1 is directed via p38-mediated phosphorylation-dependent acetylation. J Biol Chem 284: 18851-18862.
8. Dubois B, Feldman HH, Jacova C, Dekosky ST, Barberger-Gateau P, Cummings J, et al, (2007) Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 6: 734-746.
9. Fan QW, Yu W, Senda T, Yanagisawa K, Michikawa M, (2001) Cholesterol-dependent modulation of tau phosphorylation in cultured neurons. J Neurochem 76: 391-400.
10. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al, Alzheimer's Disease International (2005) Global prevalence of dementia: a Delphi consensus study. Lancet 366: 2112-2117.
11. Fontalba A, Gutierrez O, Llorca J, Mateo I, Berciano J, Fernandez-Luna JL, Combarros O, (2008) Deficiency of CARD8 is associated with increased Alzheimer's disease risk in women. Dement Geriatr Cogn Disord 26: 247-250.
12. Gao S, Hendrie HC, Hall KS, Hui S, (1998) The relationships between age, sex, and the incidence of dementia and Alzheimer disease: a meta-analysis. Arch Gen Psychiatry 55: 809-815.
13. Gatz M, Reynolds C, Fratiglioni L, Johansson B, Mortimer J, Berg S, et al, (2006) Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry 63: 168-174.
14. Granic I, Dolga A, Nijholt I, van Dijk G, Eisel U, (2009) Inflammation and NF-kappaB in Alzheimer's disease and diabetes. J Alzheimers Dis 16: 809-821.
15. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, et al, (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 41: 1088-1093.
16. Hixson JE, Vernier DT, (1990) Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31: 545-548.
17. Jarvik GP, Wijsman EM, Kukull WA, Schellenberg GD, Yu C, Larson EB, (1995) Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case-control study. Neurology 45: 1092-1096.
18. Kim J, Basak J, Holtzman D, (2009) The role of apolipoprotein E in Alzheimer's disease. Neuron 63: 287-303.
19. Kivipelto M, Helkala E, Laakso M, Hanninen T, Hallikainen M, Alhainen K, et al, (2002) Apolipoprotein E epsilon4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease. Ann Intern Med 137: 149-155.
20. Kok E, Haikonen S, Luoto T, Huhtala H, Goebeler S, Haapasalo H, Karhunen PJ, (2009) Apolipoprotein E-dependent accumulation of Alzheimer disease-related lesions begins in middle age. Ann Neurol 65: 650-657.
21. Komulainen K, Alanne M, Auro K, Kilpikari R, Pajukanta P, Saarela J, et al, (2006) Risk alleles of USF1 gene predict cardiovascular disease of women in two prospective studies. PLoS Genet 2: e69.
22. Kovacs DM, Wasco W, Witherby J, Felsenstein KM, Brunel F, Roeder RG, Tanzi RE, (1995) The upstream stimulatory factor functionally interacts with the Alzheimer amyloid beta-protein precursor gene. Hum Mol Genet 4: 1527-1533.
23. Kristiansson K, Ilveskoski E, Lehtimaki T, Peltonen L, Perola M, Karhunen PJ, (2008) Association analysis of allelic variants of USF1 in coronary atherosclerosis. Arterioscler Thromb Vasc Biol 28: 983-989.
24. Kuo YM, Emmerling MR, Bisgaier CL, Essenburg AD, Lampert HC, Drumm D, Roher AE, (1998) Elevated low-density lipoprotein in Alzheimer's disease correlates with brain abeta 1-42 levels. Biochem Biophys Res Commun 252: 711-715.
25. Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, et al, (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 41: 1094-1099.
26. Laurila PP, Naukkarinen J, Kristiansson K, Ripatti S, Kauttu T, Silander K, et al, (2010) Genetic association and interaction analysis of USF1 and APOA5 on lipid levels and atherosclerosis. Arterioscler Thromb Vasc Biol 30: 346-352.
27. Lee JC, Lusis AJ, Pajukanta P, (2006) Familial combined hyperlipidemia: upstream transcription factor 1 and beyond. Curr Opin Lipidol 17: 101-109.
28. Lehtimäki T, Pirttilä T, Mehta PD, Wisniewski HM, Frey H, Nikkari T, (1995) Apolipoprotein E (apoE) polymorphism and its influence on ApoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease. Hum Genet 95: 39-42.
29. Martins IJ, Berger T, Sharman MJ, Verdile G, Fuller SJ, Martins RN, (2009) Cholesterol metabolism and transport in the pathogenesis of Alzheimer's disease. J Neurochem 111: 1275-1308.
30. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, et al, (1991) The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41: 479-486.
31. Naukkarinen J, Gentile M, Soro-Paavonen A, Saarela J, Koistinen HA, Pajukanta P, et al, (2005) USF1 and dyslipidemias: converging evidence for a functional intronic variant. Hum Mol Genet 14: 2595-2605.
32. Notkola IL, Sulkava R, Pekkanen J, Erkinjuntti T, Ehnholm C, Kivinen P, et al, (1998) Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology 17: 14-20.
33. Pajukanta P, Lilja HE, Sinsheimer JS, Cantor RM, Lusis AJ, Gentile M, et al, (2004) Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1). Nat Genet 36: 371-376.
34. Pirttilä T, Soininen H, Mehta PD, Heinonen O, Lehtimäki T, Bogdanovic N, et al, (1997) Apolipoprotein E genotype and amyloid load in Alzheimer disease and control brains. Neurobiol Aging 18: 121-127.
35. Reiner AP, Carlson CS, Jenny NS, Durda JP, Siscovick DS, Nickerson DA, Tracy RP, (2007) USF1 gene variants, cardiovascular risk, and mortality in European Americans: analysis of two US cohort studies. Arterioscler Thromb Vasc Biol 27: 2736-2742.
36. Salero E, Gimenez C, Zafra F, (2003) Identification of a non-canonical E-box motif as a regulatory element in the proximal promoter region of the apolipoprotein E gene. Biochem J 370: 979-986.
37. Savioz A, Leuba G, Vallet PG, Walzer C, (2009) Contribution of neural networks to Alzheimer disease's progression. Brain Res Bull 80: 309-314.
38. Shibata N, Ohnuma T, Higashi S, Higashi M, Usui C, Ohkubo T, et al, (2006) Genetic association between USF 1 and USF 2 gene polymorphisms and Japanese Alzheimer's disease. J Gerontol A Biol Sci Med Sci 61: 660-662.
39. Shieh BH, Sparkes RS, Gaynor RB, Lusis AJ, (1993) Localization of the gene-encoding upstream stimulatory factor (USF) to human chromosome 1q22-q23. Genomics 16: 266-268.
40. Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG, Simons K, (1998) Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc Natl Acad Sci U S A 95: 6460-6464.
41. Steiger JL, Bandyopadhyay S, Farb DH, Russek SJ, (2004) cAMP response element-binding protein, activating transcription factor-4, and upstream stimulatory factor differentially control hippocampal GABABR1a and GABABR1b subunit gene expression through alternative promoters. J Neurosci 24: 6115-6126.
42. Stephens M, Donnelly P, (2003) A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73: 1162-1169.
43. Stephens M, Smith NJ, Donnelly P, (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68: 978-989.
44. Tabuchi A, Sakaya H, Kisukeda T, Fushiki H, Tsuda M, (2002) Involvement of an upstream stimulatory factor as well as cAMP-responsive element-binding protein in the activation of brain-derived neurotrophic factor gene promoter I. J Biol Chem 277: 35920-35931.
45. Tan ZS, Seshadri S, Beiser A, Wilson PW, Kiel DP, Tocco M, et al, (2003) Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study. Arch Intern Med 163: 1053-1057.
46. Wolozin B, Kellman W, Ruosseau P, Celesia GG, Siegel G, (2000) Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme a reductase inhibitors. Arch Neurol 57: 1439-1443.
47. Yanagisawa K, (2002) Cholesterol and pathological processes in Alzheimer's disease. J Neurosci Res 70: 361-366.
48. Yang XP, Freeman LA, Knapper CL, Amar MJ, Remaley A, Brewer HB Jr, Santamarina-Fojo S, (2002) The E-box motif in the proximal ABCA1 promoter mediates transcriptional repression of the ABCA1 gene. J Lipid Res 43: 297-306.